OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Diffuse Large B-Cell Lymphoma Refractory reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 918 reports · 45 co-occurring drugs

As of the last recalculation, Diffuse Large B-Cell Lymphoma Refractory appears in 918 FAERS reports alongside 45 co-occurring drug terms. The strongest observed disproportionality signal is POLATUZUMAB VEDOTIN (PRR 290.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Polatuzumab Vedotin110290.2293.5
Ifosfamide165212.1213.7
Doxorubicin348142.0142.6
Selinexor51141.4142.2
Doxorubicin Hydrochloride160134.3135.0
Vincristine Sulfate139126.6127.2
Etoposide283125.7126.2
Cytarabine226112.8113.2
Rituximab45093.793.9
Bendamustine Hcl5890.590.8
Cyclophosphamide Injection, Solution39186.586.7
Cyclophosphamide39186.586.7
Cyclophosphamide For Injection39186.586.7
Gemcitabine11978.578.8
Gemcitabine Hydrochloride15076.476.6
Cisplatin18667.467.6
Axicabtagene Ciloleucel2866.366.5
Mesna Injection1336.236.2
Mesna1335.535.6
Filgrastim5031.831.9
Obinutuzumab2231.031.1
Oxaliplatin8829.629.7
Erythropoietin2528.328.4
Carboplatin13327.627.6
Prednisolone17827.527.5
Prednisolone Oral17827.527.5
Prednisolone Oral Solution17827.527.5
Dexamethasone Sodium Phosphate1227.127.2
Bendamustine Hydrochloride1426.926.9
Dexamethasone 1.5 Mg24425.425.4
Epoetin Alfa1325.225.3
Dexamethasone24425.025.1
Meropenem3324.124.2
Fludarabine Phosphate3923.423.5
Prednisolone Acetate919.919.9
Valacyclovir Hydrochloride5418.418.4
Cefepime Hydrochloride1217.117.1
Febuxostat Tablets 40 Mg715.715.7
Febuxostat Tablets 80 Mg715.715.7
Entecavir815.715.7
Daptomycin614.814.8
Thiotepa614.314.3
Brentuximab Vedotin511.111.1
Venetoclax249.09.1
Lenalidomide814.74.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.